TABLE 2.
The association of the immune signature with clinicopathological characteristics in Ruijin cohort.
| Features | Total | Score level |
p-value | |
| High | Low | |||
| Gender | 0.2518 | |||
| Male | 63 | 42 | 21 | |
| Female | 38 | 21 | 17 | |
| Age | 0.0757 | |||
| ≤60 | 46 | 33 | 13 | |
| >60 | 55 | 30 | 25 | |
| Tumor size | 0.5461 | |||
| ≤4 cm | 82 | 50 | 32 | |
| >4 cm | 19 | 13 | 6 | |
| Vascular invasion | 0.7750 | |||
| Yes | 55 | 35 | 20 | |
| No | 46 | 28 | 18 | |
| Lymph node metastasis | 0.3263 | |||
| Yes | 62 | 41 | 21 | |
| No | 39 | 22 | 17 | |
| Differentiation | 0.0145* | |||
| Well/moderate | 15 | 18 | ||
| Poor | 48 | 20 | ||
| TNM stage | 0.1340 | |||
| I | 19 | 9 | 10 | |
| II + III + IV | 82 | 54 | 28 | |
*P < 0.05.